JP4611565B2 - Fat synthesis accelerator and cosmetics - Google Patents

Fat synthesis accelerator and cosmetics

Info

Publication number
JP4611565B2
JP4611565B2 JP2001137981A JP2001137981A JP4611565B2 JP 4611565 B2 JP4611565 B2 JP 4611565B2 JP 2001137981 A JP2001137981 A JP 2001137981A JP 2001137981 A JP2001137981 A JP 2001137981A JP 4611565 B2 JP4611565 B2 JP 4611565B2
Authority
JP
Japan
Prior art keywords
fat synthesis
various
cosmetics
present
extracts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2001137981A
Other languages
Japanese (ja)
Other versions
JP2002302416A5 (en
JP2002302416A (en
Inventor
幹人 伊原
友広 寺内
一博 末次
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Naris Cosmetics Co Ltd
Original Assignee
Naris Cosmetics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naris Cosmetics Co Ltd filed Critical Naris Cosmetics Co Ltd
Priority to JP2001137981A priority Critical patent/JP4611565B2/en
Publication of JP2002302416A publication Critical patent/JP2002302416A/en
Publication of JP2002302416A5 publication Critical patent/JP2002302416A5/ja
Application granted granted Critical
Publication of JP4611565B2 publication Critical patent/JP4611565B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

【0001】
【産業上の利用分野】
本発明は、各植物の各種抽出物を有効成分とした脂肪合成促進効果有することを特徴とする脂肪合成促進剤および化粧料に関するものである。特に、本発明にかかる化粧料は、女性らしい「ふっくら」した輪郭の形成、乳房の豊胸用化粧料の提供を主たる目的とするものであるが、さらには、本発明の利用分野は前記化粧料の化粧品分野にとどまるものではなく、医薬品および食品等々の各種技術分野にも広く応用できるものである。
【0002】
【従来の技術および発明が解決しようとする課題】
近年、ダイエットを中心とした健康志向が各方面でクローズアップされてきており、特に女性にとって、美しく痩せていることは永遠の望みにもなっている。当然のことながら、化粧品分野でもこの点に関心が深まり、これまで様々なスリミング製品が店頭に並んできた。
【0003】
その反面で「女性らしさを保ちたい」という点から、逆に頬骨の下や目の下、顔のくぼみ等を「ふっくら」させたり、女性の美の象徴とも言える乳房を豊胸したいという願望もある。その背景には、美しくバランスのとれた体型へと女性達の願望がある。
【0004】
一般的に「ふっくら」させる方法として、皮膚真皮細胞外マトリックスにおけるコラーゲン(膠原線維)やエラスチン(弾力線維)の代謝を改善する方法もあるが効果的でなく、むしろ、「ふっくら」させる要因の大半を占める脂肪組織の増大および蓄積が最も有効的で直接的であると考える。
【0005】
また、脂肪組織の増大及び蓄積は、組織を構成する脂肪細胞が脂肪を合成することによってなされるが、頬骨の下や目の下、顔のくぼみや乳房では、下腿部などと比較して脂肪合成作用が低く、脂肪分解作用が高い特徴があり、女性らしい「ふっくら」した輪郭の形成、乳房の豊胸には、この脂肪細胞における脂肪合成を促進させ、脂肪組織の増大及び蓄積を促すことが必要である。しかしながら、これらを解決する脂肪合成促進剤および化粧料は、これまで見い出されていなかった。
【0006】
以上のことから、女性らしい「ふっくら」した輪郭の形成、頬骨の下や目の下、顔のくぼみや乳房等の脂肪細胞における脂肪合成を促進させ、脂肪組織の増大及び蓄積を促す脂肪合成促進剤および化粧料が望まれていた。
【0007】
【課題を解決するための手段】
そこで、発明者らは、上記課題に鑑み鋭意検討を重ねた結果、種々の植物の抽出物に脂肪合成促進効果を有することを見い出した。
【0008】
すなわち、本発明は、カワカワ(Piper methysticum Forst.)、クマツヅラ(Verbena officinalis L.)、コハコベ(Stellaria media(L.)Vill.)、セイヨウタンポポ(Taraxacum officinale Weber,Taraxacum sect.Ruderalia species)、セイヨウナツユキソウ(Filipendura ulmaria(L.)Maxim.)、ヒマワリ(Helianthus annuus L.)、マヨラナ(Origanum majorana L.)、ムラサキツメクサ(Trifoliumpratense L.)、ラタニィ(Krameria triandraRuiz et Par.)から選択される1種又は2種以上の植物の抽出物が副作用も無く安全で、且安定な脂肪合成促進剤効果を有すること見い出し、それらの有効成分を含有することを特徴とする脂肪合成促進剤および化粧料を提供することある。
【0009】
【発明の実施の形態】
以下、本発明を詳述する。本発明で使用する「カワカワ(Piper methysticum Forst.)」は、Polynesia産コショウ科(Piperaceae)の灌木で、一般にカワカワと呼ばれている植物全てを用いることができる。
【0010】
本発明で使用する「クマツヅラ(Verbena officinalis L.)」は、クマツヅラ科(Verbenaceae)の薬草(Herbs)で、一般にクマツヅラと呼ばれている植物全てを用いることができる。
【0011】
本発明で使用する「コハコベ(Stellaria media(L.)Vill.)」は、ナデシコ科(Caryophyllaceae)の薬草(Herbs)で、一般にハコベと呼ばれている植物全てを用いることができる。
【0012】
本発明で使用する「セイヨウタンポポ(Taraxacum officinale Weber,Taraxacumsect.Ruderalia species)」は、キク科(Rosaceae)の薬草(Herbs)で、一般にタンポポと呼ばれている植物全てを用いることができる。
【0013】
本発明で使用する「セイヨウナツユキソウ(Filipendura ulmaria(L.)Maxim.)」は、バラ科(Rosaceae)の薬草(Herbs)で、一般にセイヨウナツユキソウと呼ばれている植物全てを用いることができる。
【0014】
本発明で使用する「ヒマワリ(Helianthus annuus L.)」は、キク科(Compositae)の薬草(Herbs)で、一般にヒマワリと呼ばれている植物全てを用いることができる。
【0015】
本発明で使用する「マヨラナ(Origanum majorana L.)」は、シソ科(Labiatae)の薬草(Herbs)で、一般にマヨラナと呼ばれている植物全てを用いることができる。
【0016】
本発明で使用する「ムラサキツメクサ(Trifolium pratense L.)」は、マメ科(Leguminosae)の薬草(Herbs)で、一般にツメクサと呼ばれている植物全てを用いることができる。
【0017】
本発明で使用する「ラタニィ(Krameria triandra Ruiz et Par.)」は、南米産マメ科(Leguminosae)の小灌木で、一般にラタニィと呼ばれている植物全てを用いることができる。
【0019】
また、各植物の各種抽出物は、各植物の花、全草またはその葉、枝、樹皮、根等の一部又は全ての箇所(以下「原体」と称する)を乾燥し、又は乾燥することなく粉砕した後、水および/又はメタノール、エタノール、プロパノール等の低級アルコール又は低級アルコール水溶液、プロピレングリコール、1.3−ブチレングリコール、グリセリン等の多価アルコール又は多価アルコール水溶液を単独および/又は2種類以上の溶媒を任意に組み合わせて使用することができる。
【0020】
各植物の低級アルコールによる抽出液は、ソックスレー抽出器を用いて抽出液を得ることができる。そして、各種植物抽出物は、低級アルコール、各種有機溶媒又は有機溶媒水溶液抽出液については各々低級アルコール、有機溶媒を留去して減圧濃縮し、また、水抽出物についてはその抽出液を減圧濃縮した後、凍結乾燥して、それぞれの抽出物を得ることができる。なお、具体的な各種植物抽出物の調製例は、実施例の項において詳述する。
【0021】
本発明にかかる脂肪合成促進剤における各種有効成分(各植物の各種抽出物)の配合量(含有量)は、前記有効成分の種類及びその組合せ、ならびにその使用目的、態様、使用形態、使用回数等々に応じて変動させることができるので、特に限定されない。原則的には、有効量存在すればよいことになるが、一般的には脂肪合成促進剤の各組成物に対して0.0001〜100重量%、好ましくは1〜10重量%が利用できる。さらにまた、本発明にかかる有効成分(各植物の各種抽出物)は1種類でも作用効果を発揮することができるが、2種類以上の有効成分を適宜組み合わせて利用することより、優れた相乗効果を奏することが期待できる。
【0022】
本発明にかかる各植物の各種抽出物に関する脂肪合成促進効果の測定は、次の方法に実施した。
【0023】
脂肪合成促進効果は、脂肪細胞前駆細胞株(マウス3T3−L1:大日本製薬製)を用い測定した。すなわち、脂肪細胞中のトリグリセライド(中性脂肪)をイソプロパノールで抽出した後、アセチルアセトンを用いて定量し、それぞれ有効成分の有無の検索を行った。なお、具体的な測定方法および脂肪合成促進率(%)の算出方法は、実施例の項において詳述する。
【0024】
脂肪組織の増大、蓄積は、組織を構成する脂肪細胞が脂肪を合成することによってなされるが、頬骨の下や目の下、顔のくぼみや乳房では、下腿部などと比較して脂肪合成作用が低く、脂肪分解作用が高い特徴があり、女性らしい「ふっくら」した輪郭の形成、乳房の豊胸には、この脂肪細胞における脂肪合成を促進させ、脂肪組織の増大及び蓄積を促すことが必要である。したがって、脂肪合成を促進させることは、女性らしい「ふっくら」した輪郭を形成、乳房を豊胸させる手段として重要である。また、本発明にかかる脂肪合成促進剤は各植物の各種抽出物に存在するものであり、極めて優れた脂肪合成促進効果を有し、しかも安定な特性を有するものである。従って、本発明にかかる脂肪合成促進剤効果を有する各種植物抽出物は、医薬品および食品等々の産業分野に利用が可能である。
【0025】
すなわち、本発明にかかる脂肪合成促進剤および化粧料は、カワカワ(Piper methysticum Forst.)、クマツヅラ(Verbenaofficinalis L.)、コハコベ(Stellaria media(L.)Vill.)、セイヨウタンポポ(Taraxacum officinale Weber,Taraxcacum sect.Ruderalia species)、セイヨウナツユキソウ(Filipendura ulmaria(L.)Maxim.)、ヒマワリ(Helianthus annuus L.)、マヨラナ(Origanum majorana L.)、ムラサキツメクサ(Trifolium pratense L.)、ラタニィ(Krameria triandra Ruiz et Par.)から選択される1種又は2種以上の植物の抽出物を含有してなる脂肪合成促効果を特徴とするものである。
【0026】
例えば、本発明にかかる各種有効成分の1種又は2種以上を各種化粧料基剤等で配合して、クリーム、乳液、化粧水、パック剤、洗顔料などの各種基礎化粧料、ファンデーション、ほほ紅、口紅、白粉などの各種メーキャップ料、石鹸、オーデコロンなど、その他化粧料に対して広範囲に適用できる。また、前記各種化粧料の態様は、溶液、エマルジョン、軟膏、オイル、ワックス、ゾル、ゲル、パウダー、スプレーなどの各種態様で適用できる。
【0027】
【作用】
本発明にかかる各植物の各種抽出物は、前述のとおり、副作用が無く安全でしかも安定な脂肪合成促進剤の1種または2種以上を有効成分として含有する化粧料を提供することができるため、よって女性らしい「ふっくら」した輪郭の形成、とりわけ乳房の豊胸を達成できる。
【0028】
【実施例】
次に、実施例により本発明をさらに詳細に説明するが、本発明はこれらの実施例により制限されるものではない。なお、実施例中の部は、特に断りのない限り重量部を示す。
【0029】
1.各種植物抽出物の調製例
(1)調製例1(水抽出物):前記各植物の原体2〜5gを円筒濾紙に入れ、イオン交換水50〜100mlに浸し、60℃で8時間加熱抽出してロ液を得た。この操作を3回繰り返し、全てのロ液を合せて凍結乾燥して各植物の水抽出物を得た。
(2)調製例2(各種低級アルコール抽出物):抽出溶媒に各種低級アルコールを用い、ソックスレー抽出器を用いて8時間抽出した後、溶媒を留去、抽出物を粉末にして各植物の各種低級アルコール抽出物を得た。
(3)調製例3(各種有機溶媒または有機溶媒水溶液抽出物):前記水抽出物における抽出操作において、水の代わりに各種有機溶媒または有機溶媒水溶液を使用した。全ての抽出液を合せて可能な限り溶媒を留去、濃縮した後、凍結乾燥して各植物の各種有機溶媒または有機溶媒水溶液抽出物を得た。
【0030】
2.脂肪合成促進効果の測定方法
まず、(1)10容量%CS含有DMEM培地、(2)分化誘導培地を調製する。
(1)10容量%CS含有DMEM培地:DMEM培地(IBC Biomedicals社製)13.48gに蒸留水1L加え、それぞれ終濃度10容量%CS(CALF BOVINE SERUM)、0.1重量%炭酸水素ナトリウム、70mg/Lストレプトマイシン硫酸塩および70mg/Lベンジルペニシリンカリウムを添加して調製する。
(2)分化誘導培地:DMEM培地(IBC Biomedicals社製)13.48gに蒸留水1L加え、それぞれ終濃度10容量%CS(CALF BOVINE SERUM)、10μg/mLインシュリン、0.5mmol/L1−メチル−3−イソブチルキサンチン(MIX)、0.25μmol/Lデキサメサゾン(DEX)、0.1重量%炭酸水素ナトリウム、70mg/Lストレプトマイシン硫酸塩および70mg/Lベンジルペニシリンカリウムを添加して調製する。
【0031】
脂肪細胞前駆細胞株(マウス3T3−L−1:大日本製薬)を10容量%CS含有DMEM培地培地にて1×10個/mLに調製し、6穴プレート(I型コラーゲンコート)に2mLずつ播種して、5%炭酸ガス、飽和水蒸気下、37℃で培養した。
【0032】
各試料(純分約1重量%)を、10容量%CS含有DMEM培地で希釈して1容量%供試料添加溶液(純分約0.1mg/mL)とした。なお、ブランクとして10容量%CS含有DMEM培地、陽性対照としてβ−エストラジオール、比較対照としてダイズおよびカッコン抽出物を試験に供した。
【0033】
Confiuent(約3日)後、培養液を吸引除去し、PBS(−)で細胞を1回洗浄した後、分化誘導培地1.8mL、各供試料添加溶液0.2mLを加え、2日間分化誘導/培養した。
【0034】
2日間の分化誘導/培養後、培養液を吸引除去し、PBS(−)で細胞を1回洗浄する。次に、0.25重量%トリプシン溶液で脂肪細胞を剥離し、上清を取り除いた後、PBS(−)で脂肪細胞を回収して試験液を得た。
【0035】
試験液にイソプロパノールを加えて混合後、類似呈色を示すリン脂質、糖および遊離グリセリンを吸着剤(活性アルミナ)に吸着させ、遠心分離し、上清のトリグリセライドを得る。次いでトリグリセライドに5%水酸化カリウムを加えけん化させ、グリセリンを遊離させた後、緩衝液(2.4mol/L酢酸アンモニウム緩衝液(pH5.5),11重量%イソプロパノール)を加えpHを6にし、50mmol/Lメタ過ヨウ素酸ナトリウム液でグリセリンを酸化させる。この結果、グリセリンから1分子のギ酸と2分子のホルムアルデヒドが生成される。生成したホルムアルデヒドはアセチルアセトンおよび緩衝液中のアンモニアと反応して環状化合物(3,5−ジアセチル−1,4−ジヒドロルチジン)を生じ、410nmに吸収極大をもつ黄色溶液(測定液)となる。
【0036】
96穴マイクロプレートに測定液を移し、プレートリーダー:410nmにおける試料の吸光度(Es)およびブランクの吸光度(Eb)を測定した。この発明にかかる各植物の各種抽出物の脂肪合成促進効果は、数1により脂肪合成促進率(%)を算出して表した。結果は表1に示した。
【0037】
【数1】

Figure 0004611565
【0038】
【表1】
Figure 0004611565
【0039】
これらの結果より、本発明にかかる各植物の各種抽出物に脂肪合成促進効果が認められる。
【0040】
3.化粧料の処方例
本発明にかかる各植物の各種抽出物を用いて、本発明にかかる化粧料を作成した。なお、配合割合は重量部である。
【0041】
(1)処方例1(化粧水)
Figure 0004611565
〔製法〕前記原料を精製水に加え均一に混合する。
【0042】
(2)処方例2(化粧用クリーム)
Figure 0004611565
Figure 0004611565
〔製法〕前記水相の原料を混合し、加熱して70℃に保ち水相部とする。一方、油相の原料を混合し、加熱溶解して70℃として油相部とする。この油相部を前述の水相部に加えて予備乳化を行ない、ホモミキサー均一に乳化し、30℃まで冷却し化粧用クリームを得る。
【0043】
(3)処方例3(化粧用乳液)
Figure 0004611565
〔製法〕前記水相の原料を混合し、加熱して70℃に保ち水相部とする。一方、他の原料を混合し、加熱溶解して70℃として油相部とする。この油相部を前述の水相部に加えて乳化し、30℃まで冷却し化粧用乳液を得る。
【0044】
(4)処方例4(パック剤)
Figure 0004611565
Figure 0004611565
〔製法〕水相の原料を混合し、均一にする。さらに他の原料を混合し、均一になるまで攪拌してパック剤を得る。
【0045】
(5)処方例5(クリーム状ファンデーション)
Figure 0004611565
〔製法〕油相の一部と粉体を3本ロールミルにかけ、残りの油相を加え加熱溶解させ、80℃に保つ。次に、加熱溶解した水相を徐々に加えて80℃で乳化し、これを攪拌しながら室温まで冷却して、クリーム状ファンデーションを得る。
【0046】
4.化粧料の効果試験例
さらに、本発明にかかる化粧料を用いて、実際に使用した場合の効果について検討を行った。
【0047】
処方例2のラタニィ(Krameria triandra Ruiz etPar.)抽出物を含有する化粧用クリームについて、女性らしい「ふっくら」した輪郭の形成、乳房の豊胸を望む16〜30歳の20名をパネラーとし、1ヶ月間毎日、朝と夜の2回、顔面および乳房全体に塗布してもらい、使用テストを実施した。対照には、ラタニィ(Krameriatriandra Ruiz et Par.)抽出物を除いたプラセボクリームを同様な方法にて処方したものを用いた。また、評価方法は、下記の基準で、実感面を評価してもらった。結果は表2のごとくで、表中の数値は人数を表す。なお、使用期間中に皮膚の異常を訴えた者はなかった。
【0048】
〔評価基準〕
有効:明らかに女性らしい「ふっくら」した輪郭の形成、乳房の豊胸を実感することができた。やや有効:やや女性らしい「ふっくら」した輪郭の形成、乳房の豊胸を実感することができた。無効:使用前と変化なし。
【0049】
【表2】
女性らしい「ふっくら」した輪郭の形成効果
Figure 0004611565
【表3】
乳房の豊胸効果
Figure 0004611565
【0051】
上記の結果より、本発明にかかる化粧料に女性らしい「ふっくら」した輪郭の形成、乳房の豊胸効果が認められる。
【0052】
【発明の効果】
各植物の各種抽出物が有する脂肪合成促進効果に基づいた、優れた脂肪合成促進剤および化粧料が提供できる。しかも、前記脂肪合成促進剤は、各植物の各種抽出物に含まれる天然物であるため、副作用も少なく安全で、しかも熱などに安定であり、前記化粧料の化粧品分野はもとより医薬品および食品等々の各種技術分野にも広く途を拓くなど、発明の目的を達成する顕著な効果を奏することが期待できる。[0001]
[Industrial application fields]
The present invention relates to a fat synthesis promoter and a cosmetic having a fat synthesis promoting effect using various extracts of plants as active ingredients. In particular, the cosmetics according to the present invention are mainly intended for the formation of feminine “fluffy” contours, and the provision of cosmetics for breast augmentation. The present invention is not limited to cosmetics, but can be widely applied to various technical fields such as pharmaceuticals and foods.
[0002]
[Background Art and Problems to be Solved by the Invention]
In recent years, health-consciousness centering on diet has been highlighted in various fields, and for women in particular, being beautiful and thin is an eternal hope. Naturally, in the cosmetics field, interest in this point deepened, and various slimming products have been lined up in stores.
[0003]
On the other hand, from the point of “I want to maintain femininity”, there is also a desire to increase the breast which can be said to be a symbol of women's beauty, such as “fluffing” under the cheekbones, under the eyes and indentations of the face. In the background there are women's desire for a beautifully balanced figure.
[0004]
In general, there is a method to improve the metabolism of collagen (collagen fibers) and elastin (elastic fibers) in the dermal extracellular matrix, but it is not effective. The increase and accumulation of adipose tissue occupying is considered the most effective and direct.
[0005]
In addition, adipose tissue is increased and accumulated by the fat cells that compose the tissue synthesizing fat, but in the lower part of the cheekbone, under the eyes, in the face of the face, and in the breast, compared with the lower leg, etc. Low action, high lipolytic action, formation of feminine “fluffy” contours, breast augmentation promotes fat synthesis in this adipocyte and promotes the growth and accumulation of adipose tissue is necessary. However, fat synthesis promoters and cosmetics that solve these problems have not been found so far.
[0006]
From the above, formation of feminine “fluffy” contours, fat synthesis promoters that promote fat synthesis in adipocytes under cheekbones and under eyes, facial depressions and breasts, and promote the increase and accumulation of adipose tissue and Cosmetics were desired.
[0007]
[Means for Solving the Problems]
In view of the above problems, the inventors have conducted extensive studies and found that various plant extracts have an effect of promoting fat synthesis.
[0008]
That is, the present invention includes Kawamekawa (Piper meticicum Forst.), Veronica officinalis L., Kochakobe (Stellaria media (L.) Vill.), Dandelion (Traxacum officinale Web). (From Filipendura ulmaria (L.) Maxim.), Sunflower (Helianthus annuus L.), Majorana (Origanum majorana L.), r. To provide a fat synthesis accelerator and cosmetics characterized in that extracts of plants of more than seeds have safe and stable fat synthesis promoter effects without side effects and contain these active ingredients. is there.
[0009]
DETAILED DESCRIPTION OF THE INVENTION
The present invention is described in detail below. As used in the present invention, “Pipemethystum Forst.” Is a shrub of Polynesia pepper family (Piperaceae), and all plants generally called Kawakawa can be used.
[0010]
The “Verbena officinalis L.” used in the present invention is a herb of Verbenaceae, and all plants generally referred to as “Penaceae” can be used.
[0011]
As used in the present invention, “Stellaria media (L.) Vill.” Is a herb of the family Caryophyllaceae, and all the plants generally referred to as “Hakobe” can be used.
[0012]
“Taraxacum officinale Weber, Taraxacumsect. Ruderaria species” used in the present invention is a herb of the Rosaceae family, and all plants generally called dandelions can be used.
[0013]
As used in the present invention, “Filipendura ulmaria (L.) Maxim.” Is a herb of the Rosaceae family and can be used for all plants generally referred to as “hermits”. .
[0014]
The “sunflower (Helianthus annuus L.)” used in the present invention is a herb of the Compositae family, and all plants generally called sunflowers can be used.
[0015]
"Majorana (L.)" used in the present invention is a herb of the Labiatae family, and all plants generally called Majorana can be used.
[0016]
"Trifolium platense L." used in the present invention is a herb of Leguminosae (Herbs), and all plants generally called clover can be used.
[0017]
As used in the present invention, “Ratani (Krameria triandra Ruiz et Par.)” Is a small shrub of the South American leguminae family (Leguminosae), and all plants generally called ratani can be used.
[0019]
In addition, various extracts of each plant dry or dry some or all of the plants (flowers, whole grass or its leaves, branches, bark, roots, etc.) (hereinafter referred to as “original”). After pulverizing without using water and / or lower alcohol or lower alcohol aqueous solution such as methanol, ethanol and propanol, polyhydric alcohol or polyhydric alcohol aqueous solution such as propylene glycol, 1.3-butylene glycol and glycerin alone and / or Two or more kinds of solvents can be used in any combination.
[0020]
An extract of each plant with a lower alcohol can be obtained using a Soxhlet extractor. The various plant extracts are concentrated under reduced pressure by distilling off the lower alcohol and the organic solvent for the lower alcohol, various organic solvents or organic solvent aqueous solution extract, and the extract is concentrated under reduced pressure for the water extract. After that, each extract can be obtained by freeze-drying. Specific preparation examples of various plant extracts will be described in detail in the Examples section.
[0021]
The compounding amount (content) of various active ingredients (various extracts of each plant) in the fat synthesis accelerator according to the present invention is the type and combination of the active ingredients, the purpose of use, the mode, the mode of use, the number of uses. Since it can be changed according to, etc., it is not particularly limited. In principle, an effective amount may be present, but generally 0.0001 to 100% by weight, preferably 1 to 10% by weight, can be used for each composition of the fat synthesis accelerator. Furthermore, the active ingredient (various extracts of each plant) according to the present invention can exert its effect even if it is a single type, but an excellent synergistic effect is obtained by appropriately combining two or more types of active ingredients. Can be expected.
[0022]
The measurement of the fat synthesis promotion effect regarding the various extracts of each plant according to the present invention was carried out by the following method.
[0023]
The effect of promoting fat synthesis was measured using an adipocyte precursor cell line (mouse 3T3-L1: manufactured by Dainippon Pharmaceutical). That is, triglyceride (neutral fat) in adipocytes was extracted with isopropanol and then quantified using acetylacetone, and each was searched for the presence or absence of active ingredients. In addition, the specific measuring method and the calculation method of fat synthesis acceleration | stimulation rate (%) are explained in full detail in the section of an Example.
[0024]
The increase and accumulation of adipose tissue is done by the fat cells that compose the tissue synthesize fat, but the fat synthesis action is lower in the cheekbones, under the eyes, in the face dents and in the breast compared to the lower leg. Low, high lipolytic characteristics, feminine “fluffy” contour formation, breast augmentation, it is necessary to promote fat synthesis in this adipocyte and promote the growth and accumulation of adipose tissue. is there. Therefore, promoting fat synthesis is important as a means of forming a feminine “fluffy” contour and breast augmentation. Moreover, the fat synthesis promoter according to the present invention is present in various extracts of each plant, has an extremely excellent fat synthesis promoting effect, and has stable characteristics. Therefore, the various plant extracts having the effect of promoting fat synthesis according to the present invention can be used in industrial fields such as pharmaceuticals and foods.
[0025]
That is, the fat synthesis promoter and cosmetics according to the present invention include Kawakawa (Piper methysticum Forst.), Vermiofficinalis L., Kochakobe (Stellaria media (L.) Vill.), Tanaxacum tsec (Web). Ruderalia species), Eustoma edulis (Filipendura ulmaria (L.) Maxim.), Sunflower (Helianthus annuus L.), nira (Origanum majorana L.), murasa (Origanum majora L.) t Par.) is characterized in fat synthesis prompting effect comprising the extract of one or more plants selected from.
[0026]
For example, one or more kinds of various active ingredients according to the present invention are blended with various cosmetic bases and the like, and various basic cosmetics such as creams, emulsions, lotions, packs, facial cleansers, foundations, cheeks, etc. It can be applied to a wide range of other cosmetics such as various make-up materials such as red, lipstick and white powder, soap and eau de cologne. The various cosmetics can be applied in various forms such as solutions, emulsions, ointments, oils, waxes, sols, gels, powders and sprays.
[0027]
[Action]
As described above, the various extracts of each plant according to the present invention can provide a cosmetic containing one or more fat synthesis promoters that are safe and have no side effects as active ingredients. Therefore, feminine “fluffy” contours, especially breast augmentation, can be achieved.
[0028]
【Example】
EXAMPLES Next, although an Example demonstrates this invention further in detail, this invention is not restrict | limited by these Examples. In addition, the part in an Example shows a weight part unless there is particular notice.
[0029]
1. Preparation Examples of Various Plant Extracts (1) Preparation Example 1 (Water Extract): 2-5 g of the original plant is placed in a cylindrical filter paper, immersed in 50-100 ml of ion-exchanged water, and heated and extracted at 60 ° C. for 8 hours. The filtrate was obtained. This operation was repeated three times, and all the filtrates were combined and freeze-dried to obtain an aqueous extract of each plant.
(2) Preparation Example 2 (Various lower alcohol extracts): Various lower alcohols were used as extraction solvents and extracted for 8 hours using a Soxhlet extractor. A lower alcohol extract was obtained.
(3) Preparation Example 3 (various organic solvents or organic solvent aqueous solution extracts): In the extraction operation in the water extract, various organic solvents or organic solvent aqueous solutions were used instead of water. All extracts were combined, and the solvent was distilled off as much as possible, concentrated, and then lyophilized to obtain various organic solvents or organic solvent aqueous extracts of each plant.
[0030]
2. Method for measuring fat synthesis promoting effect First, (1) 10 volume% CS-containing DMEM medium and (2) differentiation induction medium are prepared.
(1) 10% by volume CS-containing DMEM medium: 1L of distilled water was added to 13.48 g of DMEM medium (manufactured by IBC Biomedicals), each having a final concentration of 10% by volume CS (CALF BOVINE SERUM), 0.1% by weight sodium bicarbonate, Prepare by adding 70 mg / L streptomycin sulfate and 70 mg / L benzylpenicillin potassium.
(2) Differentiation induction medium: 1 L of distilled water was added to 13.48 g of DMEM medium (manufactured by IBC Biomedicals), each with a final concentration of 10 vol% CS (CALF BOVINE SERUM), 10 μg / mL insulin, 0.5 mmol / L1-methyl- Prepare by adding 3-isobutylxanthine (MIX), 0.25 μmol / L dexamethasone (DEX), 0.1 wt% sodium bicarbonate, 70 mg / L streptomycin sulfate and 70 mg / L benzylpenicillin potassium.
[0031]
Adipocyte progenitor cell line (mouse 3T3-L-1: Dainippon Pharmaceutical Co., Ltd.) was prepared to 1 × 10 5 cells / mL in 10% by volume CS-containing DMEM medium, and 2 mL was added to a 6-well plate (type I collagen coat). Each seed was seeded and cultured at 37 ° C. under 5% carbon dioxide gas and saturated steam.
[0032]
Each sample (pure content of about 1% by weight) was diluted with 10% by volume CS-containing DMEM medium to give a 1% by volume sample addition solution (pure content of about 0.1 mg / mL). In addition, 10 volume% CS-containing DMEM medium as a blank, β-estradiol as a positive control, and soybean and cuckoo extract as comparative controls were used for the test.
[0033]
After the Confient (about 3 days), the culture medium is removed by aspiration, and the cells are washed once with PBS (−). Then, 1.8 mL of differentiation induction medium and 0.2 mL of each sample addition solution are added to induce differentiation for 2 days. / Cultured.
[0034]
After differentiation induction / culture for 2 days, the culture medium is removed by aspiration, and the cells are washed once with PBS (−). Next, the adipocytes were detached with a 0.25 wt% trypsin solution, the supernatant was removed, and then the adipocytes were collected with PBS (−) to obtain a test solution.
[0035]
After adding isopropanol to the test solution and mixing, phospholipid, sugar and free glycerin showing similar colors are adsorbed on an adsorbent (activated alumina) and centrifuged to obtain the triglyceride of the supernatant. Next, 5% potassium hydroxide was added to triglyceride to saponify, and glycerin was liberated. Then, a buffer solution (2.4 mol / L ammonium acetate buffer solution (pH 5.5), 11% by weight isopropanol) was added to adjust the pH to 6, Glycerol is oxidized with 50 mmol / L sodium metaperiodate solution. As a result, one molecule of formic acid and two molecules of formaldehyde are produced from glycerin. The generated formaldehyde reacts with acetylacetone and ammonia in the buffer to produce a cyclic compound (3,5-diacetyl-1,4-dihydrolutidine), which becomes a yellow solution (measurement solution) having an absorption maximum at 410 nm.
[0036]
The measurement solution was transferred to a 96-well microplate, and the absorbance of the sample at 410 nm (Es) and the absorbance of the blank (Eb) at 410 nm were measured. The fat synthesis promoting effect of the various extracts of each plant according to the present invention was expressed by calculating the fat synthesis promoting rate (%) by Equation 1. The results are shown in Table 1.
[0037]
[Expression 1]
Figure 0004611565
[0038]
[Table 1]
Figure 0004611565
[0039]
From these results, the effect of promoting fat synthesis is recognized in various extracts of each plant according to the present invention.
[0040]
3. Cosmetic formulation examples Cosmetics according to the present invention were prepared using various extracts of the plants according to the present invention. In addition, a mixture ratio is a weight part.
[0041]
(1) Formulation example 1 (lotion)
Figure 0004611565
[Production method] The raw material is added to purified water and mixed uniformly.
[0042]
(2) Formulation example 2 (cosmetic cream)
Figure 0004611565
Figure 0004611565
[Manufacturing Method] The raw materials for the aqueous phase are mixed and heated to 70 ° C. to obtain an aqueous phase part. On the other hand, oil phase raw materials are mixed and dissolved by heating to 70 ° C. to obtain an oil phase part. This oil phase part is added to the above-mentioned aqueous phase part to carry out preliminary emulsification, and the homomixer is uniformly emulsified and cooled to 30 ° C. to obtain a cosmetic cream.
[0043]
(3) Formulation Example 3 (cosmetic emulsion)
Figure 0004611565
[Manufacturing Method] The raw materials for the aqueous phase are mixed and heated to 70 ° C. to obtain an aqueous phase part. On the other hand, other raw materials are mixed and dissolved by heating to 70 ° C. to obtain an oil phase part. This oil phase part is added to the aforementioned aqueous phase part to emulsify, and cooled to 30 ° C. to obtain a cosmetic emulsion.
[0044]
(4) Formulation Example 4 (packing agent)
Figure 0004611565
Figure 0004611565
[Manufacturing method] The raw materials of the aqueous phase are mixed and made uniform. Further, other raw materials are mixed and stirred until uniform to obtain a pack agent.
[0045]
(5) Formulation Example 5 (Cream Foundation)
Figure 0004611565
[Production method] Part of the oil phase and powder are put on a three-roll mill, and the remaining oil phase is added and dissolved by heating, and kept at 80 ° C. Next, the water phase dissolved by heating is gradually added and emulsified at 80 ° C., and this is cooled to room temperature while stirring to obtain a creamy foundation.
[0046]
4). Example of effect test of cosmetics Furthermore, the effects when actually used were examined using the cosmetics according to the present invention.
[0047]
For cosmetic cream containing the extract of Ratania (Krameria triandra Ruiz et Par.) In Formulation Example 2, the panelists consisted of 20 people aged 16-30 years who wanted feminine “fluffy” contours and breast augmentation. A use test was conducted by applying it to the face and the entire breast twice daily in the morning and night. As a control, a placebo cream excluding rattania (Krameria triandra Ruiz et Par.) Extract formulated in the same manner was used. In addition, the evaluation method was evaluated based on the following criteria. The results are as shown in Table 2, and the numbers in the table represent the number of people. No one complained of skin abnormalities during the period of use.
[0048]
〔Evaluation criteria〕
Effective: Clearly feminine “fluffy” contour formation and breast augmentation were realized. Slightly effective: I was able to feel the formation of a “fluffy” contour that was somewhat feminine and breast augmentation. Invalid: No change before use.
[0049]
[Table 2]
The effect of creating a feminine “fluffy” contour
Figure 0004611565
[Table 3]
Breast augmentation effect
Figure 0004611565
[0051]
From the above results, it is recognized that the cosmetic according to the present invention has a feminine “fluffy” contour formation and a breast augmentation effect.
[0052]
【The invention's effect】
It is possible to provide an excellent fat synthesis promoter and cosmetic based on the fat synthesis promoting effect of various extracts of each plant. Moreover, since the fat synthesis promoter is a natural product contained in various extracts of each plant, it is safe with few side effects and stable to heat, etc. In addition to the cosmetic field of the cosmetics, pharmaceuticals, foods, etc. It can be expected that the present invention achieves remarkable effects, such as opening up a wide range of technical fields.

Claims (1)

クマツヅラ(Verbena officinalis L.)、コハコベ(Stellaria media(L.)Vill.)、セイヨウナツユキソウ(Filipendura ulmaria(L.)Maxim.)、マヨラナ(Origanum majorana L.)ラタニィ(Krameria triandra Ruiz et Par.)から選択される1種又は2種以上の抽出物を含有してなる脂肪合成促進剤。 Verbena officinalis L., Stellaria media (L.) Vill., Firendura ulmaria (L.) Maxim., Majorana (Origanum la. A fat synthesis promoter comprising one or more extracts selected from the group consisting of:
JP2001137981A 2001-03-30 2001-03-30 Fat synthesis accelerator and cosmetics Expired - Lifetime JP4611565B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001137981A JP4611565B2 (en) 2001-03-30 2001-03-30 Fat synthesis accelerator and cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001137981A JP4611565B2 (en) 2001-03-30 2001-03-30 Fat synthesis accelerator and cosmetics

Publications (3)

Publication Number Publication Date
JP2002302416A JP2002302416A (en) 2002-10-18
JP2002302416A5 JP2002302416A5 (en) 2006-01-05
JP4611565B2 true JP4611565B2 (en) 2011-01-12

Family

ID=18984992

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001137981A Expired - Lifetime JP4611565B2 (en) 2001-03-30 2001-03-30 Fat synthesis accelerator and cosmetics

Country Status (1)

Country Link
JP (1) JP4611565B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005187431A (en) * 2003-12-26 2005-07-14 Shiseido Co Ltd Fat accumulation promoting composition
KR101296153B1 (en) 2011-06-10 2013-08-20 (주)제주사랑농수산 Cosmetic composition for pore-minimizing using scoria

Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61178908A (en) * 1984-02-27 1986-08-11 Kanebo Ltd Skin cosmetic
JPH0482837A (en) * 1990-07-26 1992-03-16 Indena Spa Neolignan deriuative and phospholipid composite, method of its use and pharmaceutical and cosmetic preparation containing said composite
JPH05229930A (en) * 1992-02-19 1993-09-07 Kanebo Ltd Skin-whitening cosmetic
JPH0812565A (en) * 1994-06-29 1996-01-16 Shiseido Co Ltd Skin external preparation
JPH08175957A (en) * 1994-12-27 1996-07-09 Kao Corp Skin agent for external use
JPH08245410A (en) * 1995-03-10 1996-09-24 Kao Corp Lipolysis promoter
JPH09291038A (en) * 1995-12-12 1997-11-11 Ennagram Sarl Mixture of plant extract including treatment of local part of symptom of local excessive skinfold thickness and its use
JPH1036279A (en) * 1996-07-18 1998-02-10 Ichimaru Pharcos Co Ltd Fibroblast proliferation promoting agent containing vegetable extract
JPH10276717A (en) * 1997-04-11 1998-10-20 Kiyaratsutsu Internatl:Kk Production of food for making woman bosomy
JPH11189541A (en) * 1997-12-26 1999-07-13 Eag Kk Therapeutic agent for melanogenetic insufficiency
JPH11292898A (en) * 1998-03-15 1999-10-26 Protein Technol Internatl Inc Isoflavone-deficient vegetable protein and vegetable protein composition containing isoflavone-containing material
JP2000154113A (en) * 1998-11-18 2000-06-06 Ichimaru Pharcos Co Ltd Cosmetic composition containing moisturizing plant extract
JP2000507609A (en) * 1996-10-17 2000-06-20 インデナ エッセ.ペ.ア. Drugs with antibacterial activity and cosmetic preparations
JP2000507958A (en) * 1996-10-17 2000-06-27 インデナ エッセ.ペ.ア. Drugs and cosmetic preparations with anti-acne activity
JP2000302667A (en) * 1999-04-23 2000-10-31 Kobe Tennenbutsu Kagaku Kk Accelerator for ample breasts
JP2002503257A (en) * 1998-02-27 2002-01-29 ブロック ドラッグ カンパニー インコーポレイテッド Stable herbal toothpaste

Patent Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61178908A (en) * 1984-02-27 1986-08-11 Kanebo Ltd Skin cosmetic
JPH0482837A (en) * 1990-07-26 1992-03-16 Indena Spa Neolignan deriuative and phospholipid composite, method of its use and pharmaceutical and cosmetic preparation containing said composite
JPH05229930A (en) * 1992-02-19 1993-09-07 Kanebo Ltd Skin-whitening cosmetic
JPH0812565A (en) * 1994-06-29 1996-01-16 Shiseido Co Ltd Skin external preparation
JPH08175957A (en) * 1994-12-27 1996-07-09 Kao Corp Skin agent for external use
JPH08245410A (en) * 1995-03-10 1996-09-24 Kao Corp Lipolysis promoter
JPH09291038A (en) * 1995-12-12 1997-11-11 Ennagram Sarl Mixture of plant extract including treatment of local part of symptom of local excessive skinfold thickness and its use
JPH1036279A (en) * 1996-07-18 1998-02-10 Ichimaru Pharcos Co Ltd Fibroblast proliferation promoting agent containing vegetable extract
JP2000507609A (en) * 1996-10-17 2000-06-20 インデナ エッセ.ペ.ア. Drugs with antibacterial activity and cosmetic preparations
JP2000507958A (en) * 1996-10-17 2000-06-27 インデナ エッセ.ペ.ア. Drugs and cosmetic preparations with anti-acne activity
JPH10276717A (en) * 1997-04-11 1998-10-20 Kiyaratsutsu Internatl:Kk Production of food for making woman bosomy
JPH11189541A (en) * 1997-12-26 1999-07-13 Eag Kk Therapeutic agent for melanogenetic insufficiency
JP2002503257A (en) * 1998-02-27 2002-01-29 ブロック ドラッグ カンパニー インコーポレイテッド Stable herbal toothpaste
JPH11292898A (en) * 1998-03-15 1999-10-26 Protein Technol Internatl Inc Isoflavone-deficient vegetable protein and vegetable protein composition containing isoflavone-containing material
JP2000154113A (en) * 1998-11-18 2000-06-06 Ichimaru Pharcos Co Ltd Cosmetic composition containing moisturizing plant extract
JP2000302667A (en) * 1999-04-23 2000-10-31 Kobe Tennenbutsu Kagaku Kk Accelerator for ample breasts

Also Published As

Publication number Publication date
JP2002302416A (en) 2002-10-18

Similar Documents

Publication Publication Date Title
KR101363413B1 (en) A cosmetic composition comprising the complex extract of salicornia herbacea l. and phragmitis rhizoma
JP3415198B2 (en) External preparation for skin
JP2002020225A (en) Humectant composition
JP2001513491A (en) Use of ginsenoside Rb1 to promote elastin synthesis
JP2020529420A (en) New cosmetic use of Nepherium rappaceum extract
EP1003538B1 (en) Use of polygonatum extracts for stimulating dermal elastin synthesis
KR20040043192A (en) Substances capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof
AU2002347271B2 (en) Cosmetic composition for human skin and hair care
JP2004067590A (en) Female sex hormone production promoter and skin preparation for external use containing the same
JP2004323406A (en) Humectant, method for using plant extract and external preparation
JP2002370922A (en) Cosmetic containing japanese plum extract
KR20170137465A (en) Composition for improving skin condition comprising herb extracts mixture
JP3370289B2 (en) Cosmetic and method for producing cosmetic
KR102130243B1 (en) A cosmetic composition for skin whitening, anti-wrinkle, anti-aging, and anti-oxidation containing glutathione, natural spicule powder, acetyl hexapeptide and broussonetia kazinoki extract
JP2004026740A (en) Cosmetic
JP4611565B2 (en) Fat synthesis accelerator and cosmetics
KR20160003918A (en) Cosmetic composition for enhancing skin elasticity or improving skin wrinkle containing herb extracts
KR20090105222A (en) The cosmetic composition for the reduction of skin pores
JPS63239208A (en) Beauty or skin composition containing silymarine-rich extract of silybum marianum fruit and essential fatty acid
JP3447667B2 (en) External preparation for skin
JP2003277226A (en) External preparation for skin
KR101154501B1 (en) A composition of eliminating keratin comprising saussurea involucratae extract
KR20200058730A (en) A composition for preventing hair loss or promoting hair growth
JP3504590B2 (en) External preparation for skin
KR20150051751A (en) Composition for treating hair or scalp to prevent hair loss

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051114

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080229

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20100617

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100629

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100830

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20101012

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20101014

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131022

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4611565

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term